4//SEC Filing
PERSKY MARLA 4
Accession 0001867096-25-000147
CIK 0001867096other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:09 PM ET
Size
6.2 KB
Accession
0001867096-25-000147
Insider Transaction Report
Form 4
PERSKY MARLA
Director
Transactions
- Sale
Common Stock
2025-09-11$7.72/sh−15,500$119,610→ 142,000 total
Holdings
- 6,370(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.650 to $7.840, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001270354
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 5:09 PM ET
- Size
- 6.2 KB